VRNA - Verona Pharma PLC Qarzning balans kapitallashuviga nisbati

Verona Pharma PLC (VRNA) grafik logotipi

Verona Pharma plc (VRNA) zararli gazlarsiz ekologik toza inhalatorlarni joriy etmoqda, bu esa kompaniyaning ESG tamoyillariga sodiqligini tasdiqlaydi. Qarzning bozor kapitalizatsiyasiga nisbati dinamikasi moliyaviy holatni aniq ko'rsatadi, bunda 0.83 qiymati joriy ko'rsatkich vazifasini o'taydi. Strategik ittifoqlar respirator kasalliklar davolash vositalarining chiqarilishini tezlashtirmoqda, ishchi kapitalning yetarliligi esa sotuvlar boshlanganda marketingni barqaror moliyalashtirishni kafolatlaydi.

VRNA (Verona Pharma Inc.) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 18.10.2025gacha

Verona Pharma PLC (VRNA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Verona Pharma plc|VRNA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Verona Pharma Inc.|VRNA - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Verona Pharma|VRNA - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati veronapharma.com|VRNA - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Verona Pharma plc|VRNA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Verona Pharma Corp|VRNA - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Verona Pharma Inc.|VRNA - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Verona Pharma
Kompaniyaning barcha koʻrsatkichlari tahlili:VRNA Verona Pharma plc
Verona Pharma Corp asosiy tovari

Verona Pharma plc (VRNA) uchun komponentlar logistikasi va klinik sinovlardagi geosiyosiy uzilishlarga qarshi chidamlilik bevosita moliyaviy avtonomiya darajasiga bog'liq. Majburiyatlarning balans kapitalizatsiyasiga nisbatan joriy tuzilishini tahlil qilish orqali investor qarzning kapitalga nisbati koeffitsientini baholaydi: ushbu koeffitsientning pasayishi defolt xavfini minimallashtiradi va global beqarorlik sharoitida kompaniyaning dori vositalarini ishlab chiqishni mustaqil ravishda moliyalashtirish qobiliyatini tasdiqlaydi.

Verona Pharma plc raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Jyong Biotech (MENS)|LGND: Qarzning sof aktivlarga nisbati|AMRX (Amneal Pharmaceuticals Inc) - Qarzning balans kapitallashuviga nisbati|Perrigo Corp (PRGO) - Qarzning balans qiymatiga nisbati|ALVO (Alvotech) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar liquidia.com (LQDA)|Galapagos (GLPG) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati ANIP (ANI Pharmaceuticals Inc)|MNKD: Qarzning balans kapitallashuviga nisbati|AMPH - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Pacira BioSciences PCRX|SPRY - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc (AQST) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar SCPH (scPharmaceuticals, Inc.)|Balans qiymatiga qarzlar TECX|Tonix Pharmaceuticals (TNXP) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati sxtchina.com SXTC|Qarzning balans qiymatiga nisbati Eupraxia Pharmaceuticals Inc. EPRX|Qarzning balans kapitallashuviga nisbati BioHarvest Sciences, Inc. BHST|EXOZ (Invizyne Technologies, Inc.) - Balans kapitallashuviga qarzlar|ORMP: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati enterabio.com ENTX|HYFT (ipatherapeutics.com) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ABVC (ABVC BioPharma, Inc.)|Balans qiymatiga qarzlar CPIX|Qarzning balans kapitallashuviga nisbati Quantum BioPharma Limited QNTM|Qarzning balans qiymatiga nisbati FibroGen Corporation (FGEN)|Balans kapitallashuviga qarzlar TELO (Telomir Pharmaceuticals)|RANI - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Synergy CHC Corporation (SNYR)|RLYB: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati lexariabioscience.com (LEXX)|Pulmatrix Corporation (PULM) - Qarzlarning balans kapitallashuviga nisbati|PTHL - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Aptorum|Balans kapitallashuviga qarzlar LYRA|Balans kapitallashuviga qarzlar IBO (Impact BioMedical, Inc.)|Qarzning balans kapitallashuviga nisbati TNF Pharmaceuticals, Inc.|cbdMD Inc. - Qarzning sof aktivlarga nisbati|PRFX: Qarzning balans kapitallashuviga nisbati|CYTO - Qarzning balans qiymatiga nisbati|LIPO: Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar OptiNose Inc|PIRS - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati PROC|PTPI - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati QLI (qlsyy.net)|Qarzning balans kapitallashuviga nisbati ACELYRIN SLRN|Qarzning balans kapitallashuviga nisbati TFF Pharmaceuticals Inc. TFFP